These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38454763)

  • 1. Remedial Dosing Recommendations for Sirolimus Delayed or Missed Dosages Caused by Poor Medication Compliance in Pediatric Tuberous Sclerosis Complex Patients.
    Yang Y; Jiang L; Zhu HR; Sun WX; Mao JY; Miao JW; Wang YC; He SM; Wang DD; Chen X
    Curr Pharm Des; 2024; 30(11):877-886. PubMed ID: 38454763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remedial dosing recommendations for delayed or missed doses of lamotrigine in pediatric patients with epilepsy using Monte Carlo simulations.
    Yu EQ; Jiao Z; Wang CY; Ding JJ; Zhang XH
    Epilepsy Behav; 2019 Jul; 96():132-140. PubMed ID: 31132614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remedial dosing recommendations for delayed or missed doses of valproic acid in patients with epilepsy based on Monte Carlo simulations.
    Wang CY; Jiao Z; Ding JJ; Yu EQ; Zhu GX
    Epilepsy Behav; 2020 Oct; 111():107265. PubMed ID: 32640410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacokinetic Analysis and Dosing Optimization of Sirolimus in Children With Tuberous Sclerosis Complex.
    Li S; Zhan M; Wu S; Liao J; Xu H; Sun D; Zhao X; Wang Y
    J Clin Pharmacol; 2022 Aug; 62(8):948-959. PubMed ID: 35094415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Handling Delayed or Missed Dose of Antiseizure Medications: A Model-Informed Individual Remedial Dosing.
    Li ZR; Wang CY; Lin WW; Chen YT; Liu XQ; Jiao Z
    Neurology; 2023 Feb; 100(9):e921-e931. PubMed ID: 36450606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Dosage Recommendation for Sirolimus in Children With Tuberous Sclerosis Complex.
    Wang DD; Chen X; Xu H; Li ZP
    Front Pharmacol; 2020; 11():890. PubMed ID: 32595509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-Informed individualized dosage regimen of sirolimus in pediatric patients with intractable lymphatic malformations.
    Liu B; Zhang X; Zhao Y; Xu X; Wang S; Wang X; Cheng X
    Eur J Pharm Sci; 2024 Sep; 200():106837. PubMed ID: 38960206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to handle the delayed or missed dose of rivaroxaban in patients with non-valvular atrial fibrillation: model-informed remedial dosing.
    Liu XQ; Yin YW; Wang CY; Li ZR; Zhu X; Jiao Z
    Expert Rev Clin Pharmacol; 2021 Sep; 14(9):1153-1163. PubMed ID: 34058934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberous Sclerosis Complex in 29 Children: Clinical and Genetic Analysis and Facial Angiofibroma Responses to Topical Sirolimus.
    Wang S; Liu Y; Wei J; Zhang J; Wang Z; Xu Z
    Pediatr Dermatol; 2017 Sep; 34(5):572-577. PubMed ID: 28771801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing delayed or missed pregabalin doses in patients with focal epilepsy: a Monte Carlo simulation study.
    Xie H; Zheng Y; Wang C; Song S; Dai Y; Huang X; Liu M; Wu X
    Int J Clin Pharm; 2024 Feb; 46(1):150-157. PubMed ID: 37991662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus improves seizure control in pediatric patients with tuberous sclerosis: A prospective cohort study.
    He W; Chen J; Wang YY; Zhang MN; Qian-Lu ; Wang QH; Luo XM; Chen XQ; Zou LP
    Seizure; 2020 Jul; 79():20-26. PubMed ID: 32416565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Pharmacokinetics and Initial Dose Optimization of Sirolimus Improving Drug Blood Level for Seizure Control in Pediatric Patients With Tuberous Sclerosis Complex.
    Chen X; Wang D; Zhu L; Lu J; Huang Y; Wang G; Zhu Y; Ye Q; Wang Y; Xu H; Li Z
    Front Pharmacol; 2021; 12():647232. PubMed ID: 33995061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Nonadherence on Levetiracetam Pharmacokinetics and Remedial Dose Recommendations Using Monte Carlo Simulations.
    Methaneethorn J
    Eur J Drug Metab Pharmacokinet; 2022 Sep; 47(5):667-676. PubMed ID: 35761145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of poor compliance on the pharmacokinetics of carbamazepine and its epoxide metabolite using Monte Carlo simulation.
    Ding JJ; Zhang YJ; Jiao Z; Wang Y
    Acta Pharmacol Sin; 2012 Nov; 33(11):1431-40. PubMed ID: 23103621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effects of Topical 0.2% Sirolimus for Angiofibromas in Adults and Pediatric Patients with Tuberous Sclerosis Complex.
    Lee YI; Lee JH; Kim DY; Chung KY; Shin JU
    Dermatology; 2018; 234(1-2):13-22. PubMed ID: 29925060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-based precision dosing and remedial dosing recommendations for delayed or missed doses of isoniazid in Chinese patients with tuberculosis.
    Li JM; Zhang RY; Yang GY; Cai QS; Lang YZ; Zhong FM; Huang JP; Chen YY; Qin Y; Fang LK; Ye B; Lin LH; Lin HH; Cai XJ; Xu K
    Br J Clin Pharmacol; 2024 Apr; ():. PubMed ID: 38570184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first study in pediatric: Population pharmacokinetics of sirolimus and its application in Chinese children with immune cytopenia.
    Cheng X; Zhao Y; Gu H; Zhao L; Zang Y; Wang X; Wu R
    Int J Immunopathol Pharmacol; 2020; 34():2058738420934936. PubMed ID: 32720540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to handle a missed or delayed dose of lacosamide in pediatric patients with epilepsy? a mode-informed individual dosing.
    Wang J; Mei Y; Liang S; Li SC; Chen C; Nie G; Tuo YL; Sun D; Wang Y
    Epilepsy Behav; 2024 Feb; 151():109601. PubMed ID: 38194771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience.
    Krueger DA; Capal JK; Curatolo P; Devinsky O; Ess K; Tzadok M; Koenig MK; Narayanan V; Ramos F; Jozwiak S; de Vries P; Jansen AC; Wong M; Mowat D; Lawson J; Bruns S; Franz DN;
    Eur J Paediatr Neurol; 2018 Nov; 22(6):1066-1073. PubMed ID: 30005812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Handling delayed or missed direct oral anticoagulant doses: model-informed individual remedial dosing.
    Liu XQ; Li ZR; Wang CY; Jiao Z
    Blood Adv; 2024 Sep; ():. PubMed ID: 39293087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.